DeepMind, the London-based artificial intelligence company that is owned by Alphabet Inc, plans to develop a medical product that will help doctors to detect more than 50 sight-threatening conditions from a common type of eye scan.
DeepMind trained artificial intelligence software to detect signs of disease better than human doctors, according to a study published Monday in the scientific journal Nature Medicine. DeepMind and its partners in the research, London’s Moorfields Eye Hospital and the University College London Institute of Ophthalmology, said they plan prospective clinical trials of the technology in 2019.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
